Socioeconomic Disparities

Background: Among patients with type 2 diabetes, minority racial/ethnic groups have a higher burden of cardiovascular disease, chronic kidney disease, and hypoglycaemia. These groups may especially benefit from newer diabetes medication classes, but high cost may limit access. We examined the association of race/ethnicity with the initiation of newer diabetes medications (GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors).
Objectives: A limitation in the design and monitoring of public health policies is the lack of conceptual models to explain their results. The objective of this study was to develop a predictive model of stunting in children under 5 years of age in the central Andean region of Peru, using socioeconomic and agro-productive predictors. Study design: Cross-sectional data of 380 families in 15 districts of the central region of Peru. WHO criteria were used to define stunting prediction model.